Anand Sharma to Chemoradiotherapy
This is a "connection" page, showing publications Anand Sharma has written about Chemoradiotherapy.
Connection Strength
0.074
-
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2022 02; 23(2):259-269.
Score: 0.048
-
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. J Clin Oncol. 2013 Apr 10; 31(11):1415-21.
Score: 0.026